CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,833 | +56.5% | 67,293 | +27.8% | 0.01% | +40.0% |
| Q2 2023 | $1,171 | +19.6% | 52,649 | +16.5% | 0.01% | +25.0% |
| Q1 2023 | $979 | +15.2% | 45,190 | +7.9% | 0.00% | 0.0% |
| Q4 2022 | $850 | -99.9% | 41,864 | +1.9% | 0.00% | -33.3% |
| Q3 2022 | $1,053,000 | +17.3% | 41,065 | +8.7% | 0.01% | +20.0% |
| Q2 2022 | $898,000 | +21.0% | 37,780 | +14.6% | 0.01% | +25.0% |
| Q1 2022 | $742,000 | +43.0% | 32,963 | +25.8% | 0.00% | +33.3% |
| Q4 2021 | $519,000 | +13.6% | 26,203 | +12.8% | 0.00% | 0.0% |
| Q3 2021 | $457,000 | -4.6% | 23,239 | +6.6% | 0.00% | -25.0% |
| Q2 2021 | $479,000 | -0.6% | 21,794 | +7.6% | 0.00% | 0.0% |
| Q1 2021 | $482,000 | +1.7% | 20,251 | +11.8% | 0.00% | -33.3% |
| Q4 2020 | $474,000 | +76.9% | 18,106 | +17.4% | 0.01% | +50.0% |
| Q3 2020 | $268,000 | +30.7% | 15,421 | +26.4% | 0.00% | 0.0% |
| Q2 2020 | $205,000 | – | 12,199 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |